Zomelis

AllProPremium

Healthcare

04 December, 2019

Eris Lifesciences buys anti-diabetic drug from Novartis for India market

Eris Lifesciences Ltd said it has acquired the trademark for anti-diabetic drug Zomelis for $13 million (Rs 92.9 crore) from ......

Most Popular

TMT

Airbound, Mushin Innovative Labs, OnePlay pocket funding cheques

Pro

Finance

Evolvence India hits the road for fifth fund, tweaks LP strategy

Pro

Healthcare

Rivendell PE marks another full exit with a haircut

Pro

Healthcare

Carlyle hits the sell button on another Indian bet eyeing juicy returns

Finance

Peak XV leads SarvaGram's nearly $70 mn Series D round

Consumer

Blackstone eyes 20% stake in Haldiram's at $8 bn valuation

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW